ICU Medical (ICUI) Tops Q3 EPS by 16c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Piper Jaffray Reiterates Overweight Rating on ICU Medical (ICUI) Following 3Q Beat
November 6, 2015 10:10 AM ESTPiper Jaffray reiterated an Overweight rating on ICU Medical (NASDAQ: ICUI), and raised the price target to $129.00 (from $124.00), following the company's 3Q earnings report. ICUI reported 3Q15 sales and EPS of $86.0M and $1.00, which compared to consensus of $81.3M and $0.84. Two key highlights in the quarter were ICUIs continued strength in OEM sales and the long-term supply... More
